Top compounds associated with response to ERVK3-1


Feature Type Standardized
Nominal ANOVA
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.12 0.0008
mRNA TAE684 CCLE pan-cancer AAC -0.14 0.002
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA pluripotin CTRPv2 pan-cancer AAC -0.1 0.005
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.1 0.005
mRNA niclosamide CTRPv2 pan-cancer AAC -0.1 0.005
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.1 0.006
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.007
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.099 0.009
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.092 0.009
Download CSV